Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NDV-HXP-S vaccine in healthy adults previously immunized against COVID-19
NCT05181709Phase 1Completed
- Start
- Feb 2022
- Primary completion
- May 2023
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Patria in coronavirus disease 2019 (COVID-19). Started Feb 2022; status: completed.
02
Drugs
Patria
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05181709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05181709.